Pet Ct In Lymphomas

Drawing on an extensive series of cases, this book describes and illustrates in detail the FDG-PET/CT appearances of the most common lymphomas in both adults and children, covering presentations at various anatomic sites. In addition, all other aspects of the current application of FDG-PET/CT in the evaluation and management of patients with malignant lymphomas are described. Full explanations are provided of the potential benefits and limitations of advanced PET/CT techniques and technologies that support novel chemotherapy and radiotherapy approaches in the treatment of lymphoma, and particular attention is paid to the major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring. This clinical case-based atlas will be an invaluable tool for radiologists, hematologists, and clinical oncologists.

This book provides an up-to-date summary of the latest scientific developments on the use of PET-CT imaging in Non-Hodgkin Lymphoma (NHL). It encompasses the entire spectrum of NHL – from pathology to radiological and PET-CT imaging and to the management of NHL. The highlight of the book is the excellent pictorial depiction of normal variants, pitfalls and artifacts while exploring the different types of NHL and its manifestations. Each chapter, written by well-known and experienced oncologists and physicians, is enriched by a wide range of images to ensure a clear concept of PET-CT imaging in NHL and will definitely keep the readers interested. This book will be a useful tool for nuclear physicians, radiologists, referring clinicians and oncologists, as well as para-medical staff working in this field.

This issue provides a complete update on PET imaging of lymphoma, starting with a clinical assessment of lymphoma and the role of medical imaging. The role of structural imaging in lymphoma is then discussed. From a Nuclear Medicine perspective, FDG-PET in lymphoma is reviewed, as is the role of FDG-PET in pediatric lymphoma. Next, the role of non-FDG tracers in lymphoma is reviewed. Other articles cover the role of fMRI and optical imaging in lymphoma, the role of diffusion-weighted MRI in lymphoma, FDG-PET in personalization of therapy in patients with lymphoma, and PET and radiation oncology in lymphoma.

Drawing on an extensive series of cases, this book describes and illustrates in detail the FDG-PET/CT appearances of the most common lymphomas in both adults and children, covering presentations at various anatomic sites. In addition, all other aspects of the current application of FDG-PET/CT in the evaluation and management of patients with malignant lymphomas are described. Full explanations are provided of the potential benefits and limitations of advanced PET/CT techniques and technologies that support novel chemotherapy and radiotherapy approaches in the treatment of lymphoma, and particular attention is paid to the major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring. This clinical case-based atlas will be an invaluable tool for radiologists, hematologists, and clinical oncologists.

This pocket book is an up-to-date guide to the diagnostic imaging of head and neck cancers. The focus is particularly on FDG PET/CT, with coverage of the basic principles, clinical indications, typical and atypical appearances, normal variations and artifacts, advantages, limitations, and pitfalls. Consideration is also given to emerging roles for PET/CT in head and neck cancer, including radiotherapy planning and treatment response monitoring, and to radiotracers beyond FDG. In addition, succinct information is provided on clinical presentation, diagnosis, staging, pathology, management, and other diagnostic imaging techniques. A brief discourse on the practice of guideline adoption is included. The book is published within the Springer series Clinicians’ Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for clinicians, nuclear medicine physicians, radiologists, radiographers, technologists, and nurses who work in the field of head and neck cancer.

This book is a pocket guide to the practice of PET/CT imaging of Hodgkin’s lymphoma. The role of PET/CT in Hodgkin’s lymphoma, the characteristic findings and patterns, and the advantages and limitations of this hybrid modality are all clearly described. In addition, information is provided on clinical presentation, diagnosis, staging, pathology, management, and conventional radiological imaging. A useful pictorial atlas is included at the end of the book. PET/CT in Hodgkin’s Lymphoma is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging, which is aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. Compiled under the auspices of the British Nuclear Medicine Society, the series is the joint work of many colleagues and professionals worldwide who share a common vision and purpose in promoting and supporting nuclear medicine as an important imaging specialty for the diagnosis and management of oncological and non-oncological conditions.

This book provides an up-to-date summary of the latest scientific developments on the use of PET-CT imaging in Non-Hodgkin Lymphoma (NHL). It encompasses the entire spectrum of NHL - from pathology to radiological and PET-CT imaging and to the management of NHL. The highlight of the book is the excellent pictorial depiction of normal variants, pitfalls and artifacts while exploring the different types of NHL and its manifestations. Each chapter, written by well-known and experienced oncologists and physicians, is enriched by a wide range of images to ensure a clear concept of PET-CT imaging in NHL and will definitely keep the readers interested. This book will be a useful tool for nuclear physicians, radiologists, referring clinicians and oncologists, as well as para-medical staff working in this field.